Suppr超能文献

糖皮质激素诱导肿瘤坏死因子受体(GITR)激活在移植物抗宿主病中对同种反应性CD4(+)和CD8(+) T细胞产生相反的作用。

GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host disease.

作者信息

Muriglan Stephanie J, Ramirez-Montagut Teresa, Alpdogan Onder, Van Huystee Thomas W, Eng Jeffrey M, Hubbard Vanessa M, Kochman Adam A, Tjoe Kartono H, Riccardi Carlo, Pandolfi Pier Paolo, Sakaguchi Shimon, Houghton Alan N, Van Den Brink Marcel R M

机构信息

Department of Medicine and Immunology, Memorial Sloan-Kettering Cancer Center, Kettering 425, Mailbox 111, 1275 York Ave., New York, NY 10021, USA.

出版信息

J Exp Med. 2004 Jul 19;200(2):149-57. doi: 10.1084/jem.20040116. Epub 2004 Jul 12.

Abstract

Glucocorticoid-induced tumor necrosis factor receptor family-related gene (GITR) is a member of the tumor necrosis factor receptor (TNFR) family that is expressed at low levels on unstimulated T cells, B cells, and macrophages. Upon activation, CD4(+) and CD8(+) T cells up-regulate GITR expression, whereas immunoregulatory T cells constitutively express high levels of GITR. Here, we show that GITR may regulate alloreactive responses during graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation (BMT). Using a BMT model with major histocompatibility complex class I and class II disparity, we demonstrate that GITR stimulation in vitro and in vivo enhances alloreactive CD8(+)CD25(-) T cell proliferation, whereas it decreases alloreactive CD4(+)CD25(-) proliferation. Allo-stimulated CD4(+)CD25(-) cells show increased apoptosis upon GITR stimulation that is dependent on the Fas-FasL pathway. Recipients of an allograft containing CD8(+)CD25(-) donor T cells had increased GVHD morbidity and mortality in the presence of GITR-activating antibody (Ab). Conversely, recipients of an allograft with CD4(+)CD25(-) T cells showed a significant decrease in GVHD when treated with a GITR-activating Ab. Our findings indicate that GITR has opposite effects on the regulation of alloreactive CD4(+) and CD8(+) T cells.

摘要

糖皮质激素诱导的肿瘤坏死因子受体家族相关基因(GITR)是肿瘤坏死因子受体(TNFR)家族的成员,在未受刺激的T细胞、B细胞和巨噬细胞上低水平表达。激活后,CD4(+)和CD8(+) T细胞会上调GITR表达,而免疫调节性T细胞则组成性地高表达GITR。在此,我们表明GITR可能在异基因骨髓移植(BMT)后的移植物抗宿主病(GVHD)期间调节同种异体反应性应答。使用具有主要组织相容性复合体I类和II类差异的BMT模型,我们证明体外和体内的GITR刺激可增强同种异体反应性CD8(+)CD25(-) T细胞增殖,而降低同种异体反应性CD4(+)CD25(-)增殖。GITR刺激后,同种异体刺激的CD4(+)CD25(-)细胞凋亡增加,这依赖于Fas-FasL途径。在存在GITR激活抗体(Ab)的情况下,含有CD8(+)CD25(-)供体T细胞的同种异体移植受者的GVHD发病率和死亡率增加。相反,用GITR激活Ab治疗时,具有CD4(+)CD25(-) T细胞的同种异体移植受者的GVHD显著降低。我们的研究结果表明,GITR对同种异体反应性CD4(+)和CD8(+) T细胞的调节具有相反的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c132/2212013/7cc50b9d850f/20040116f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验